Tepperman B L, Soper B D, Chang Q, Brown J F, Wakulich C A
Department of Physiology, University of Western Ontario, London, Ontario, Canada.
Eur J Pharmacol. 2000 Feb 18;389(2-3):131-40. doi: 10.1016/s0014-2999(99)00892-4.
We have investigated whether activation of protein kinase C has a direct cytotoxic effect on colonic mucosal epithelial cells and whether oxidant-induced damage to colonocytes is mediated by activation of cellular protein kinase C. Incubation of freshly harvested cells from rat colon with the protein kinase C activator, phorbol 12-myristate, resulted in a concentration-dependent increase in the extent of cell injury. Phorbol 12-myristate acetate (0.1-10 microM) also increased cellular protein kinase C activity and this was reduced significantly by treating cells with the antagonists staurosporine or 2-[1-(3-dimethylaminopropyl)-indol-3-yl]3-(-indol-3-yl)maleimide (GF 109203X; 10 microM). Phorbol 12-myristate acetate treatment also resulted in increased translocation of proteins for protein kinase C isoforms alpha, delta and epsilon from cytosol to membrane particulate fractions. The antagonists reduced the extent of cell damage in response to phorbol 12-myristate acetate. Furthermore, cell injury in response to the phorbol acetate was also inhibited by the addition of the oxidant scavengers, superoxide dismutase or catalase to the cell suspension. Addition of H(2)O(2) to the incubation medium (0.1-100 microM) resulted in an increase in cellular protein kinase C activity, an increase in the expression of the alpha, beta and zeta isoforms and a reduction in cell integrity. The cellular damaging actions of H(2)O(2) were significantly reduced by the protein kinase C antagonists, staurosporine or 2-[1-(3-dimethylaminopropyl)-indol-3-yl]-3-(-indol-3-yl)maleimide (GF 109203X). These findings suggest that protein kinase C activation results in colonic cellular injury and this damage is mediated, at least in part, by release of reactive oxidants. Furthermore, oxidant-mediated damage to these cells also involves protein kinase C activation.
我们研究了蛋白激酶C的激活对结肠黏膜上皮细胞是否具有直接细胞毒性作用,以及氧化剂诱导的结肠细胞损伤是否由细胞蛋白激酶C的激活介导。用蛋白激酶C激活剂佛波醇12 - 肉豆蔻酸酯孵育刚从大鼠结肠收获的细胞,导致细胞损伤程度呈浓度依赖性增加。佛波醇12 - 肉豆蔻酸酯乙酸盐(0.1 - 10微摩尔)也增加了细胞蛋白激酶C的活性,用拮抗剂星形孢菌素或2 - [1 - (3 - 二甲基氨基丙基)-吲哚 - 3 - 基] - 3 - (-吲哚 - 3 - 基)马来酰亚胺(GF 109203X;10微摩尔)处理细胞可显著降低该活性。佛波醇12 - 肉豆蔻酸酯乙酸盐处理还导致蛋白激酶C同工型α、δ和ε的蛋白质从胞质溶胶向膜颗粒部分的转位增加。拮抗剂降低了对佛波醇12 - 肉豆蔻酸酯乙酸盐的细胞损伤程度。此外,向细胞悬液中添加氧化剂清除剂超氧化物歧化酶或过氧化氢酶也抑制了对佛波醇乙酸盐的细胞损伤。向孵育培养基中添加H₂O₂(0.1 - 100微摩尔)导致细胞蛋白激酶C活性增加、α、β和ζ同工型的表达增加以及细胞完整性降低。蛋白激酶C拮抗剂星形孢菌素或2 - [1 - (3 - 二甲基氨基丙基)-吲哚 - 3 - 基] - 3 - (-吲哚 - 3 - 基)马来酰亚胺(GF 109203X)显著降低了H₂O₂的细胞损伤作用。这些发现表明蛋白激酶C的激活导致结肠细胞损伤,并且这种损伤至少部分是由活性氧化剂的释放介导的。此外,氧化剂介导的这些细胞损伤也涉及蛋白激酶C的激活。